Heat Biologics Balance Sheet - Annual (NASDAQ:HTBX)

Add to My Stocks
$1.87 $0.02 (1.06%) HTBX stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Heat Biologics stock analysis. Financial strength can be guaged by performing Heat Biologics stock analysis and by analyzing the balance sheet. A company releases its balance sheet every year along with its annual results. Apart from analyzing Heat Biologics revenue Heat Biologics operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Heat Biologics balance sheet for 2017 shows cash on hand of $9.76M. The company has a debt to equity ratio of 0.

View latest 10 year balance sheet data to check Heat Biologics financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash9.76M7.84M4.94M3.71M4.56M-
Marketable Securities--6.69M10.69M17.29M-
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets1.96M---1.06M-
Total Current Assets
11.74M8.26M12.49M15.27M22.95M-
Property Plant & Equipment------
Accumulated Depreciation------
Net Property Plant & Equipment
------
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Intangibles2.18M-----
Deposits & Other Assets5.93M-----
Total Assets
20.18M8.89M13.21M15.91M23.02M-
Notes Payable------
Accounts Payable1.03M-1.98M1.36M--
Current Portion Long-Term Debt--3.13M---
Current Portion Capital Leases------
Accrued Expenses2.27M1.3M1.84M---
Income Taxes Payable------
Other Current Liabilities7.02M-----
Total Current Liabilities
10.33M1.59M6.96M2.57M1.18M-
Mortgages------
Deferred Taxes/Income1.3M-----
Convertible Debt------
Long-Term Debt--3.61M2.31M--
Non-Current Capital Leases------
Other Long-Term Liabilities2.76M-----
Total Liabilities
14.4M2.05M10.72M4.88M1.3M1.66M
Minority Interest------
Preferred Stock------
Common Stock Net------
Capital Surplus76.38M65.86M48.56M35.89M34.33M4.49M
Retained Earnings-68.84M-57M-44.43M-24.13M-12.34M-5.93M
Treasury Stock------
Other Liabilities-1.75M-2.02M-1.64M-0.72M-0.27M-0.07M
Shareholders Equity5.78M6.83M2.49M11.03M21.71M-1.51M
Total Liabilities & Shareholders Equity20.18M8.89M13.21M15.91M23.02M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Heat Biologics stock price by looking at Heat Biologics historical stock prices. One can compare PE with industry average by looking at the Heat Biologics PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Heat Biologics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for HTBX stock as of 2017 is $20.18M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Heat Biologics is $14.4M. Shareholders' equity comes under liabilities as it is money the company owes the holders of HTBX stock.

Heat Biologics Balance Sheet - Key Ratios

Current ratio
3.88
Debt to equity ratio
0
Asset turnover ratio
0.16
Receivables turnover
371.25
Price to book ratio
2.61